Calcivis CEO Adam Christie

Edinburgh-based CALCIVIS receives Approvable Letter from FDA

Mark McIntyre blog

Edinburgh, March 5th 2020 – CALCIVIS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its CALCIVIS® Imaging System from the US Food and Drug Administration (FDA). CALCIVIS intends to introduce this novel product in the US in 2021 with the …